Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | NIH Awards MoBiTec's Partner BellBrook Labs Phase II GrantNIH Awards MoBiTec's Partner BellBrook Labs Phase II Grant to Develop HTS Assays Targeting the cGAS-STING Pathway for Autoimmune Diseases and Cancer.
By: MoBiTec GmbH BellBrook's HTS Assays Universal HTS assays for enzymes using direct detection of nucleotides and homogenous fluorescent readouts. Targets include Kinases, ATPases, Phosphodiesterases, Methyltransferases, Glycosyltransferases, GTPases, and more! Four Assays Cover Thousands of Target Enzymes. Universal, high throughput screening platform for enzymes based on direct detection of nucleotide enzyme products with far red FI, FP and TR-FRET readouts. Transcreener is a universal assay method that can be used across entire families of nucleotide-dependent enzymes. Rather than using separate assays for a multitude of specific reaction products, such as phosphorylated proteins or lipids, a single nucleotide detection assay can be used for all of the enzymes that generate a common nucleotide product. For details see: https://www.mobitec.com/ All BellBrook's HTS Assays are available to MoBiTec customers throughout Europe. About MoBiTec GmbH MoBiTec GmbH (Goettingen, Germany) is a privately held company (founded in 1987) that offers research tools for molecular and cell biology. Products include DNA vectors for cloning and expression, cell transfection reagents and cell culture tools, immobilized and soluble enzymes, products for genomics and proteomics research, numerous antibodies and recombinant proteins, superior fluorescence reagents and kits, affinity chromatography products, as well as general laboratory equipment. In parallel to its own product lines, MoBiTec distributes products from international companies in Germany. MoBiTec products are distributed worldwide, in Germany from their home office, in other countries by distributors. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|